Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Comparison of newer IOL power calculation formulae with conventional ones in highly myopic eyes

Search Title by author or title

Session Details

Session Title: Cataract Surgery Outcomes: IOL Power Calculations

Session Date/Time: Sunday 08/10/2017 | 14:30-16:00

Paper Time: 15:42

Venue: Meeting Center Room I

First Author: : S.Vasavada INDIA

Co Author(s): :    V. Vasavada   V. Vasavada   S. Srivastava   A. Vasavada           

Abstract Details

Purpose:

To evaluate the predictive accuracy of newer formulae (Barrett Universal II and Hill RBF calculator) to conventional ones (SRK/T, Holladay 1, Hoffer Q) in high myopic eyes.

Setting:

Iladevi Cataract & IOL Research Centre, Raghudeep Eye Hospital, Gurukul Road, Memnagar, Ahmedabad - 380052

Methods:

Prospective, observational study in 30 eyes(30patients) undergoing cataract surgery with monofocal IOL implantation and having an axial length >26mm. Eyes with optical biometry were included, and those with staphyloma excluded. Prediction Error(PE) was calculated as(predicted refraction- actual postoperative refraction)and absolute PE(APE)=│predicted refraction-actual postoperative refraction│. Best corrected visual acuity (BCVA) and manifest refraction assessed between 3-4 months postoperatively and PE, APE compared between all four formulae.

Results:

Ongoing study, results will be updated. Early results :Mean age of patients was 61.2+5.4years.The mean(+standard deviation,SD)PE was 0.05+0.26,-0.48+0.31,-0.19+0.30 and 0.10+0.20 diopters(D) with SRK/T,Holladay I, Hoffer Q and Barrett formula respectively (RBF formula results pending). Difference in mean PE between the formulae was statistically significant (P<0.0001). SRK/T and Barrett formulae had the least PE. APE was 0.20+0.13,0.48+0.31,0.39+0.15 and 0.19+0.07D with the four formulae respectively.

Conclusions:

In eyes with an axial length >26mm, the SRK/T and Barrett formulae seemed to give best prediction results based on preliminary data (RBF formula results pending). Final conclusion will be updated based on results of ongoing study.

Financial Disclosure:

NONE

Back to previous